Loading...
Some research suggests that 24-hour ambulatory blood pressure (BP) predicts cardiovascular (CV) outcomes more accurately than does clinic BP. Now, Spanish researchers provide additional insights drawn from a national primary care–based registry. The study included 64,000 adults (mean age, 58) who had guideline-specified indications for 24-hour ambulatory BP monitoring and who were followed for a mean 5 years. Patients were categorized as having sustained hypertension (elevated clinic and ambulatory readings), white-coat hypertension (elevated clinic but not ambulatory readings), masked hypertension (elevated ambulatory but not clinic readings), or normotension.
During follow-up, all-cause and CV-related mortality were 6% and 2%, respectively. Both clinic and ambulatory BP measurements (systolic and diastolic) were associated, in graded fashion, with excess all-cause and CV-related mortality. However, in models in which clinic BP was adjusted for ambulatory BP (and vice versa), ambulatory BP predicted mortality more strongly. Interestingly, masked hypertension predicted CV mortality as strongly as did sustained hypertension (whether or not patients were receiving treatment at the time of BP measurement). White-coat hypertension in untreated patients was associated with excess mortality, whereas the white-coat pattern in treated patients was not.
Banegas JR et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality. N Engl J Med 2018 Apr 19; 378:1509. (http://dx.doi.org/10.1056/NEJMoa1712231)
Townsend RR.The value in an ambulatory blood-pressure registry. N Engl J Med 2018 Apr 19; 378:1555. (http://dx.doi.org/10.1056/NEJMe1802369)
Comment
This study validates the utility of 24-hour ambulatory BP measurement as a stronger prognostic tool than clinic measurement. Limitations include the fact that only baseline BP measurement and baseline drug-treatment status were used to predict outcomes; thus, the study didn't tell us how subsequent drug treatment of patients with the various hypertensive phenotypes (sustained, white-coat, and masked) affects outcomes. Moreover, many clinicians base treatment decisions on readings from patient-owned home BP units. Self-monitoring appears to be valuable (NEJM JW Gen Med Apr 12 2018; [e-pub] and Lancet 2018; 391:949), but additional research on how those readings compare with 24-hour ambulatory readings would be useful.